To assess how omission of adjuvant radiotherapy relates to postoperative complications and patient-reported outcomes after oncoplastic breast-conserving surgery (OPBCS).
Approach:
Design and participants: Retrospective study of consecutive adult women who underwent OPBCS within one healthcare network from 2017 through 2024. Patients were grouped according to whether they received adjuvant radiotherapy; patients who refused radiotherapy were included in the omission group.
Outcomes: Investigators recorded postoperative complications, complication-related unplanned reoperations, later revision procedures, and locoregional or distant recurrence. Long-term patient-reported outcomes were assessed using the BREAST-Q Reconstruction Module; the supplied text identifies Satisfaction with Breasts and begins naming Psychosocial but is truncated before the full measure description.
Analysis: Demographic, clinical, tumor, treatment, and surgical characteristics were abstracted from medical records. The supplied methods text does not include the full statistical-analysis description.
Interpretation:
The supplied context describes the study rationale and methods but does not report results, so comparative findings cannot be summarized.
Limitations:
The study was retrospective and conducted within one healthcare network.
The supplied context does not include study results or the complete statistical-analysis methods.
by Abbas M. Hassan, Carson Park, Kathryn Borders, Rachel M. Danforth, Ravinder Bamba, R. Jason VonDerHaar, Ivan Hadad, Mary E. Lester, Carla S. Fisher, Aladdin H. Hassanein
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.
